Sector: MedicalCritical Therapeutics, Inc. (NASDAQ: CRTX)
Headlines
- Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Nov 20, 2009 03:40 PM | CRTX
- Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
Nov 16, 2009 08:15 AM | CRTX
- Cornerstone Therapeutics Appoints General Counsel
Nov 13, 2009 08:01 AM | CRTX, LLY
- Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results
Nov 04, 2009 07:02 AM | CRTX
- Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call
Oct 21, 2009 08:01 AM | CRTX
- Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)
Sep 03, 2009 08:02 AM | CRTX
- Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences
Sep 03, 2009 08:02 AM | CRTX
- Strong Start To The Week
Jul 20, 2009 08:24 PM | AAPL, CRTX, FSYS, GS, HGSI, IFON
- Tight, Choppy Nominal Up-Session
Jul 09, 2009 07:38 PM | CRTX, CSIQ, DNDN, GS, JPM, MOS
- Choppy Up-Session
Jun 29, 2009 08:47 PM | CGA, CRTX, DNDN, GS, IFON, MOS
- Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
Aug 11, 2009 01:56 PM | CRTX
- Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
Aug 11, 2009 07:58 AM | CRTX
- Cornerstone Therapeutics Announces Closing of Chiesi Transaction
Jul 30, 2009 08:32 AM | CRTX
- Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal
Jul 20, 2009 08:02 AM | CRTX
- Cornerstone Therapeutics Submits Regulatory Filing for Extended- Release Antitussive Product
Jul 15, 2009 07:51 PM | CRTX
- Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
Jul 15, 2009 07:06 PM | CRTX
- Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
Jul 13, 2009 05:53 PM | CRTX, OSCI
- Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)
Jul 13, 2009 05:52 PM | CRTX, OSCI
- Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
Jul 08, 2009 04:16 PM | CRTX
- Cornerstone Therapeutics Joins the Russell 3000(R) Index
Jun 30, 2009 08:01 AM | CRTX
- Form 4 Powell Andrew Kenneth For: Oct 30 (10K)
Nov 03, 2009 05:16 PM
- Form 3 Powell Andrew Kenneth For: Oct 30 (10K)
Nov 03, 2009 05:13 PM
- Form 4 Franklin Joshua B For: Sep 10 (10K)
Sep 14, 2009 06:02 PM
- Form 4 Price David For: Sep 01 (10K)
Sep 03, 2009 06:54 PM
- Form 4 Dickson Brian For: Sep 02 (10K)
Sep 03, 2009 06:52 PM
- Form 4 Lutz Steven Michael For: Jul 28 (10K)
Jul 30, 2009 01:35 PM
- Form 4 CORNERSTONE THERAPEUTICS For: Jul 28 Filed by: Cornerstone BioPharma Holdings, Ltd. (10K)
Jul 30, 2009 01:28 PM
- Form 4 Collard Craig A For: Jul 28 (10K)
Jul 30, 2009 01:27 PM
- Form 4 Franklin Joshua B For: Jul 28 (10K)
Jul 30, 2009 01:25 PM
- Form 4 Dickson Brian For: Jul 28 (10K)
Jul 30, 2009 01:24 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRTX
|
Compare to S&P
|
| YTD |
116.23 %
|
78.61 %
|
| 4 Weeks |
-3.37 %
|
-3.89 %
|
| 12 Weeks |
-15.86 %
|
-21.04 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -53.85 %
|
|
EPS Growth in Last Year: 112.00 %
|
|
Sales Growth in Last Quarter: -7.66 %
|
|
Sales Growth in Last Quarter: 285.08 %
|
|
